SHORT COMMUNICATION
28 Bilateral pulmonary micronodulillary pattern. Variety of possibilities?
Anoro-Abenoza L., Lozano-Cartagena D.A., Rodero-Hernández F.J.
SUMMARY: The bilateral micronodulillary pattern involves multiple diagnostic possibilities that include inflammatory, in-fectious,
neoplastic, interstitial and autoimmune pathologies, among others. We present a clinical case with definitive diag-nosis
of carcinomatous lymphangitis secondary to pulmonary adenocarcinoma and the different diagnostic tests needed to
obtain an accurate diagnosis.
KEYWORDS: Micronodules, lung, neoplasm.
30 Abdominal aortic aneurysm. A disloyal pain.
Giner-Ruiz S., Abós-Cenarro M.T.; Estrada-Lázaro I.M.; Morales-Hernández I.,; Serrano- Moreno A. C.
SUMMARY: Abdominal aortic aneurysm (AAA) is a vascular pathology that consists of a dilation greater than 50%
of the normal diameter of the vessel or a diameter greater than or equal to 3 cm, due to a weakening of its vascular
wall. Its most frequent location is in the infrarenal portion of the aorta since it is an area subjected to important hemo-dynamic
forces. Prevalence varies depending on age, sex (6 times more frequent in males), family history of aneurysm
(increases the risk of AAA 2 times), smoking (up to 7 times more risk), high blood pressure, dyslipidemia and periph-eral
artery disease. There are studies that suggest that type 2 diabetes mellitus has a protective effect and that weight
and some respiratory pathologies, such as chronic obstructive pulmonary disease (COPD), do not influence aneurysmal
growth. Below we present the case of a patient with a remarkable oncological history who presented an abdominal
aortic aneurysm manifesting itself through low back pain. This is a clinical case that forces us to establish a wide range
of differential diagnoses of low back pain and how to approach an abdominal aortic aneurysm with new therapeutic
techniques.
KEYWORDS: back pain, aortic aneurysm; surgical procedures.
TECHNICAL NOTE
33 Positive assessment of drugs: from September, October, November and December of 2021
Gonzalo-Salado M.H., García-Sánchez S., Silva-Cuevas M., García-Luque A.
SUMMARY:The drugs assessed by the Spanish Agency for Medicines and Health Products or European Medicines Agency
made public from September to December of 2021, and considered of interest to the healthcare professional, are reviewed.
These are positive technical reports prior to the authorization and placing on the market of the product.
KEYWORDS: abrocitinib (Cibinqo®); amivantamab (Rybrevant®); anifrolumab (Saphnelo®); artesunato (Artesunato
Amivas®); avacopan (Tavneos®); casirivimab/imdevimab (Ronapreve®); diroximel fumarato (Vumerity®); enfortumab
vedotin (Padcev®); eptinezumab (Vyepti®); finerenona (Kerendia®); glucarpidasa (Voraxaze®); inebilizumab (Uplizna®);
linzagolix colina (Yselty®); lonapegsomatropina (Lonapegsomatropin Ascendis Pharma®); pegcetacoplan (Aspaveli®);
pralsetinib (Gavreto®); regdanvimab (Regkirona®); ripretinib (Qinlock®); risperidona (Okedi®); sacituzumab govitecan
(Trodelvy®); semaglutida (Wegovy®); somatrogón (Ngenla®); sotorasib (Lumykras®); sotrovimab (Xevudy®); tecovirimat
(Tecovirimat SIGA®); tepotinib (Tepmetko®); vacuna conjugada de polisacárido neumocócico adsorbido (Vaxneuvance®);
vacuna conjugada de polisacáridos neumocócicos adsorbidos 20-valente (Apexxnar®); voxelotor (Oxbryta®); zanubrutinib
(Brukinsa®).
REPORT
42 Gluten quantification in Spanish individual operational rations
Lozano-Benito D., Cereceda-Chacón A., Zamora-Benito A.
SUMMARY: Introduction: People with celiac disease can join the military training centers and and their diet during train-ing
exercises can be done through combat rations, individual or collective rations. Objective: To quantify the gluten in the
combat rations with precautionary labeling of allergens (PAL) or gluten-free in its composition. Material and Methods:
39 individual operational rations samples (23 with PAL and 16 without cereals with gluten in their composition) and 6
collective rations (without cereals with gluten in their composition) were analyzed using a commercial enzyme-linked im-munosorbent
assay (ELISA) kit. Results: All samples were below the limit of quantification (< 5mg/kg of gluten) and the
results met the quality criteria. Conclusions: The gluten results obtained on the samples and batches analyzed show a low
risk of exposure.
KEYWORDS: Celiac disease, gluten, operational rations, PAL, ELISA.
PICTURE PROBLEM
45 Lump and discomfort in the inguinal region in pregnant woman
SUMMARY: 34-year-old woman, 16 weeks pregnant, with a personal history of cervical conization and previous cesarean
section. Consultation for discomfort in the right groin region and signs of inflammation in the area, without a clear tumor.
She refers that in the first pregnancy she presented the same symptoms. In the intergestational period she has not noticed these
symptoms. On physical examination, the 16-week pregnant abdomen did not reveal clear signs of hernia, although there was
slight pain on palpation. It was decided to request a pelvic ultrasound to rule out the presence of hernia or other soft tissue
lesions in the groin region.
4 Sanid. mil. 2022; 78 (1)